Droseffik 0.02 mg - 3 mg film-coat. tabl.

Država: Belgija

Jezik: engleski

Izvor: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Kupi sada

Aktivni sastojci:

Drospirenone 3 mg (pink tablet); Ethinylestradiol 0,02 mg (pink tablet); Placebo (white tablet)

Dostupno od:

EFFIK Benelux SA-NV

ATC koda:

G03AA12

INN (International ime):

Drospirenone; Ethinylestradiol; Placebo

Doziranje:

0,02 mg - 3 mg

Farmaceutski oblik:

Film-coated tablet

Sastav:

Drospirenone 3 mg; Ethinylestradiol 0.02 mg; Placebo

Administracija rute:

Oral use

Područje terapije:

Drospirenone and Ethinylestradiol

Proizvod sažetak:

CTI code: 428407-01 - Pack size: 28 (24 + 4) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 428407-02 - Pack size: 2 x 28 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 428407-03 - Pack size: 3 x 28 (24 + 4) - Commercialisation status: YES - FMD code: 05430001224122 - CNK code: 2995744 - Delivery mode: Medical prescription; CTI code: 428407-04 - Pack size: 6 x 28 (24 + 4) - Commercialisation status: YES - FMD code: 05430001224139 - CNK code: 2995751 - Delivery mode: Medical prescription; CTI code: 428407-05 - Pack size: 13 x 28 (24 + 4) - Commercialisation status: YES - FMD code: 05430001224146 - CNK code: 2995769 - Delivery mode: Medical prescription

Status autorizacije:

Commercialised: Yes

Datum autorizacije:

2012-10-05

Dokumenti na drugim jezicima

Uputa o lijeku Uputa o lijeku njemački 08-03-2023
Uputa o lijeku Uputa o lijeku francuski 08-03-2023
Svojstava lijeka Svojstava lijeka francuski 08-03-2023
DHPC DHPC francuski 20-09-2022
Uputa o lijeku Uputa o lijeku nizozemski 08-03-2023
Svojstava lijeka Svojstava lijeka nizozemski 08-03-2023
DHPC DHPC nizozemski 20-09-2022